Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10131
Title: Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients.
Austin Authors: Bishop, Emma;Melvani, Sharmila;Howden, Benjamin P ;Charles, Patrick G P ;Grayson, M Lindsay 
Affiliation: Infectious Diseases Department, Austin Health, Studley Rd., Heidelberg, Victoria 3084, Australia
Issue Date: 1-Apr-2006
Publication information: Antimicrobial Agents and Chemotherapy; 50(4): 1599-602
Abstract: We assessed the toxicity and clinical outcomes associated with linezolid therapy (mean duration, 29+/-28 days; range, 8 to 185 days) in 44 patients with serious gram-positive infections. Although a clinical cure was achieved in 73% of the cases, 28/44 (64%) had adverse reactions (thrombocytopenia, n=13; anemia, n=7; gastrointestinal, n=12; peripheral neuropathy, n=1; serotonin syndrome, n=1), such that a systematic monitoring protocol was developed.
Gov't Doc #: 16569895
URI: http://ahro.austin.org.au/austinjspui/handle/1/10131
DOI: 10.1128/AAC.50.4.1599-1602.2006
URL: https://pubmed.ncbi.nlm.nih.gov/16569895
Type: Journal Article
Subjects: Acetamides.adverse effects
Adult
Aged
Aged, 80 and over
Anti-Infective Agents.adverse effects
Gram-Positive Bacterial Infections.drug therapy
Humans
Middle Aged
Oxazolidinones.adverse effects
Retrospective Studies
Appears in Collections:Journal articles

Show full item record

Page view(s)

12
checked on Nov 29, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.